Phase II Trial of Inotuzumab Ozogamicin in Children ... | 動物用藥查詢網
由MMO'Brien著作·2022·被引用20次—PhaseIITrialofInotuzumabOzogamicininChildrenandAdolescentsWithRelapsedorRefractoryB-CellAcuteLymphoblasticLeukemia:Children's ...
FIG 1.
Swimmers plot depicting individual patient response, subsequent therapy, and outcomes for 48 patients.…
FIG 1.Swimmers plot depicting individual patient response, subsequent therapy, and outcomes for 48 patients. Data are censored as of December 31, 2020. Patients with Down syndrome are denoted as DS. Dark bars indicate InO given on study. Initial response to cycle 1 is indicated by CR, CRi, PR, SD, or PD. For patients who received cycle 2, response is indicated as CCR or CCRi if previously achieved CR or CRi with cycle 1. Duration of initial response is indicated by color (CR or CRi = blue; PR or SD = red, PD = gray). HSCT is indicated by star, and CAR T-cell therapy is indicated by triangle. Patient 9 received six cycles of therapy on study and continued to receive commercial InO for an additional year before relapse. Patient 19 with KMT2A rearrangement received ...
ALL新藥inotuzumab ozogamicin獲健保給付 | 動物用藥查詢網
Inotuzumab ozogamicin | 動物用藥查詢網
Inotuzumab ozogamicin as single agent in pediatric patients ... | 動物用藥查詢網
Inotuzumab Ozogamicin for RelapsedRefractory ... | 動物用藥查詢網
Inotuzumab ozogamicin in the treatment of acute ... | 動物用藥查詢網
Inotuzumab ozogamicin with bosutinib for relapsed ... | 動物用藥查詢網
Inotuzumab Ozogamicin-成人急性淋巴性白血病治療新 ... | 動物用藥查詢網
Phase II Trial of Inotuzumab Ozogamicin in Children ... | 動物用藥查詢網
認識化療藥品Inotuzumab | 動物用藥查詢網
百利先12%注射劑 POLYCIDE 12% INJ
百利先12%注射劑有哪些副作用?由公源藥品股份有限公司觀音廠製造的百利先12%注射劑是治療什麼的?藥品成分是什麼?以下為大...
百利先24%注射劑 POLYCIDE 24% INJ.
百利先24%注射劑有哪些副作用?由公源藥品股份有限公司觀音廠製造的百利先24%注射劑是治療什麼的?藥品成分是什麼?以下為大...